ONO Pharmaceutical is focused on the production, purchase, and sale of pharmaceuticals and diagnostic reagents on prescription pharmaceuticals. The company focuses on drug discovery leads that are high in certainty and globally competitive. The company was started in 1717 in Dosho-machi, Osaka. Throughout its 300-year history, ONO has dedicated itself to developing innovative and breakthrough pharmaceutical products.

Cortene is a clinical-stage biopharmaceutical company focused on developing treatments for chronic fatigue syndrome and other diseases.

Kwang Dong Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following divisions: Pharmacy Sales, Hospital Sales, Distribution Sales, and Water Sales. The Pharmacy Sales division provides medicines for cold, high blood pressure, and cerebral apoplexy. The Hospital Sales division offers inoculation, health supplements, and vitamins. The Distribution Sales division provides health drinks and other drinks. The Water Sales division offers drinking water. The company was founded on October 16, 1969 and is headquartered in Seoul, South Korea.

Takara Bio Inc., develops, manufactures, and distributes a wide range of life science reagents and kits under the Takara®, Clontech®, and Cellartis® brands. Key products include SMART® cDNA synthesis kits for a variety of samples and applications, including NGS; high-performance qPCR and PCR reagents (including the Takara Ex Taq®, Takara LA Taq®, Titanium®, and Advantage® enzymes); Cellartis stem cells and stem cell reagents; RT enzymes and SMART library construction kits; the innovative In-Fusion® cloning system; Guide-it™ gene editing tools; Tet-based inducible gene expression systems; and Living Colors® fluorescent proteins. These and other products support applications including NGS; gene discovery, regulation, and function studies; protein expression and purification; RNAi, gene editing, and stem cell studies; and plant and food research

Souken Co., Ltd. is engaged in real estate business. The company offers real estate management and warehousing services. Souken was established in 1968 and is based in Tokyo, Japan.

CYBERDYNE Inc. is a venture firm which is established by Dr. Yoshiyuki Sankai, University of Tsukuba, Japan, in order to materialize his idea to utilize Robot Suit HAL® for the benefits of humankind in the field of medicine, caregiving, welfare, labor, heavy works, entertainment and so on. Robot Suit HAL® was developed with the technologies created in Sankai Laboratory of Tsukuba University as an application of “Cybernics*” advocated by Prof. Sankai.

Zeria Pharmaceutical produces veterinary pharmaceuticals, agricultural chemicals, industrial chemicals and reagents, and more. In addition, they also provide cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, and more.

Arizona Board of Regents oversees college activities. The company was founded in 1864 and is headquartered in Phoenix, AZ.

Established in 1945, Amorepacific is Korea’s No.1 beauty company and a blue-chip corporation. Amorepacific owns nearly 30 well-known brands and has been developing rapidly worldwide. Amorepacific pays great attention to product research and development through research centers located in Korea, France, Japan and Shanghai, to develop premium and high quality skincare and cosmetics products. The Group chose Hong Kong as a strategic bridgehead for the expansion of its presence across the Greater China region and the rest of the world. Two flagship brands - LANEIGE and Sulwhasoo, were introduced in Hong Kong in 2002 and 2004 respectively. The eponymous luxury brand – AMOREPACIFIC, was introduced in Hong Kong in 2014. In 2015, ETUDE HOUSE, a playful cosmetics brand, made its debut in the territory. In 2018, the Company set foot in the personal care product market, introducing the Group’s legendary hair care brand ‘Ryo’ into Hong Kong.

Lotte Wellfood Co., Ltd. engages in the manufacture and sale of various confectionary products such as dried snacks, frozen snacks, bread products and healthy functional food. Its products include chewing gums, chocolates, biscuits, ice-creams, pies, candies, and baked goods. The company was founded on October 12, 2017 and is headquartered in Seoul, South Korea.

Takara Shuzo Co. Ltd. manufactures and markets alcoholic beverages. Its products include alcoholic beverages, raw alcohol, health drinks, and seasonings. The company was founded in 1925 and is headquartered in Kyoto, Japan.

HLSCIENCE Co., Ltd. engages in the research, development, and manufacture of health functional foods. It operates through the following Businesses: Natural New Material Development, Health Functional, and Directive Products. The company was founded on September 28, 2000 and is headquartered in Hwaseong, South Korea.

Hangzhou Hangyi Biotechnology Co., Ltd., established on 2018-03-15, Business scope includes technology development,technical consulting,Technical Services,Achievement transfer:Biotechnology,Bioengineering Technology,Agricultural Technology,new material technology,new energy technology,Mechanical Equipment Technology,Biogas Technology,Environmentally friendly material technology,medical technology,Electronic product technology,Computer software and hardware technology,new technology for electrification;energy saving technology,Biotechnology promotion;technology development,Technical Services,Sales:computer software,the hardware,Electronic equipment,Teaching equipment,Ordinary machinery;Technical Services,Sales,Production:Class I medical device;

Fuso Pharmaceutical Industries, Ltd. engages in the manufacture and sale of ethical pharmaceutical and medical equipment. It operates through the Pharmaceuticals and Real Estate divisions. The Pharmaceuticals division deals with the manufacture and sale of pharmaceutical products which mainly focus on prescription drugs, infusions, and artificial kidney dialysis solutions. The Real Estate division handles leasing of real estate properties. The company was founded on March 25, 1937 and is headquartered in Osaka, Japan.

Taiho Pharmaceutical Co., Ltd. is engaged in the research, development, production, distribution, and marketing of pharmaceutical products. The company develops drugs primarily in the area of oncology. It also develops other pharmaceuticals, controlled medical devices, designated quasi-drugs, second-class OTC drugs, designated second-class OTC drugs, and third-class OTC drugs; S-1 for the treatment of gastric cancer; TAS-102 for the treatment of colorectal cancer; and anticancer agents for oncologists, other medical care professionals, and patients. In addition, it engages in the research and development in the areas of oncology,